New insider activity at Inhibrx Biosciences Inc ( (INBX) ) has taken place on October 9, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viking Global Investors Lp, a significant shareholder, has recently sold 350,000 shares of Inhibrx Biosciences Inc, amounting to a total transaction value of $11,287,500.
Spark’s Take on INBX Stock
According to Spark, TipRanks’ AI Analyst, INBX is a Neutral.
Inhibrx Biosciences Inc presents a mixed picture. The most significant factor is the weak financial performance marked by operational challenges and high leverage. However, strong technical indicators suggest bullish momentum, though caution is warranted given potential overbought conditions. Valuation metrics show a low P/E ratio, which could either signal undervaluation or market concerns about profitability. No earnings call or corporate events data is available for additional context.
To see Spark’s full report on INBX stock, click here.
More about Inhibrx Biosciences Inc
YTD Price Performance: 120.39%
Average Trading Volume: 117,124
Technical Sentiment Signal: Buy
Current Market Cap: $485.3M